Hologic will occupy two booths at this year's RSNA meeting to showcase the company's changing identity and its growing array of imaging products. One booth will feature only new technologies from each of the company's four divisions: Hologic Radiographic
Hologic will occupy two booths at this year's RSNA meeting to showcase the company's changing identity and its growing array of imaging products.
One booth will feature only new technologies from each of the company's four divisions: Hologic Radiographic Systems, which focuses on direct and general radiography; Lorad, specializing in digital and analog breast imaging and minimally invasive breast biopsy systems; Fluoroscan, which provides C-arm imaging devices for orthopedics and pain management; and Hologic Bone Densitometry Systems.
A second booth will feature a mix of new technologies and product lines from the four divisions.
Hologic and its divisions will display:
Hologic was established in 1986 as a developer, manufacturer, and marketer of proprietary x-ray and ultrasound bone analyzer systems. It is shifting focus in the hope it will become a leading provider of comprehensive radiographic solutions. If recent moves are any indication, that goal may not be unrealistic.
Hologic acquired Fluoroscan Imaging Systems in 1996 and Direct Radiography Corp. (DRC) three years later. Earlier this year the company completed its hat trick by acquiring the U.S. assets of Trex Medical, including the Lorad, Continental, and Bennett x-ray product lines.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.